Related Experiment Video
Updated: Aug 21, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
Parenteral lipids and the preterm infant: between Scylla and Charybdis
1Division of Cardiology, Hospital for Children and Adolescents, University of Helsinki, Helsinki, Finland. olli.pitkanen@sickkids.ca
Insights
Intravenous lipid infusions offer vital energy and fatty acids when enteral feeding isn't possible. However, in newborns, these infusions risk metabolic issues like oxidative stress and vascular complications, necessitating careful consideration of high PUFA content.
Area of Science:
- Neonatal nutrition
- Parenteral nutrition
- Biochemistry
Background:
- Intravenous lipid emulsions provide essential energy and fatty acids when the enteral route is not feasible.
- These infusions are crucial for critically ill infants unable to receive nutrition orally or enterally.
Discussion:
- Neonatal patients receiving intravenous lipids face potential metabolic challenges, including oxidative stress.
- Complications may arise, such as altered vascular tone, intravascular fat deposition, and fat embolism.
- High polyunsaturated fatty acid (PUFA) content in parenteral lipids warrants careful consideration in critically ill newborns.
Key Insights:
- Parenteral lipids are a necessary nutritional source in specific neonatal situations.
- Metabolic and vascular complications are significant risks associated with their use in neonates.
- The type and content of lipids, particularly PUFAs, influence risk.
Outlook:
- Further research is needed to optimize lipid formulations for neonatal parenteral nutrition.
- Strategies to mitigate oxidative stress and vascular complications should be explored.
- Clinical guidelines may need refinement regarding the use of high PUFA parenteral lipids in critically ill infants.
Abstract:
Intravenous lipid infusions are a valid option for a dense source of energy and essential fatty acids when the enteral route is unavailable. However, the use of these preparations in neonatal patients has been associated with metabolic concerns such as oxidative stress, and complications such as abnormal vascular tone, intravascular fat deposition and even fat embolism. Metabolic issues related to nutrient accretion and noxious biological reactions should be considered when prescribing parenteral lipids with high PUFA content to the critically ill newborn infant.
More Related Videos
Related Concept Videos
Parentral Nutrition: Centeral and Peripheral Parental Nutrition
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
Lipid Absorption
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Asymmetric Lipid Bilayer
Assembly of the Lipid Bilayer in the ER
A large chunk of any biological membrane is composed of phospholipids. These lipids have a heterogeneous distribution across different subcellular organelles and even between...
Lipid Digestion

